A Pitt professor is working to commercialize a discovery made in the lab of Mark Gladwin, Chairman of the Department of Medicine.
Pitt Spinout LyGenesis Raises $3 Million to Pursue Clinical Study
LyGenesis is commercializing technology developed by Eric Lagasse of the McGowan Institute for Regenerative Medicine to grow functional liver tissue inside lymph nodes.
Pitt Investigator Seeks to Reduce Radiation Exposure in Stress Tests
Pitt Spinout Peptilogics to Enter New LifeX Accelerator
Fresh off closing a $5.5 million funding round, Peptilogics will become an inaugural member of the LifeX accelerator where it will continue to devleop its therapies for antiobiotic resistant infections.
Pitt Research Shows Gene Therapy Can Reverse Diabetes in Mice
The lab of Pitt professor George Gittes said it had dicovered a viral vector gene therapy that reprogrammed pancreas cells in diabetic mice to produce insulin and maintain normal blood glucose levels for a prolonged period.